Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

SORE Study: Sitz Baths After Urogynecologic Reconstruction

NCT: NCT07215780 · ACTIVE_NOT_RECRUITING

NCT IDNCT07215780
StatusACTIVE_NOT_RECRUITING
Start Date2025-10-28
Completion2026-11-25
SponsorYale University (OTHER)
First posted
Last updated

Brief Summary

The purpose of this study is to evaluate the utility of postoperative sitz baths in patient pain perception and recovery following surgical repair of prolapse. The SORE Study is a prospective, randomized controlled trial that aims to compare postoperative pain intensity one week after native tissue repair of pelvic organ prolapse for patients undergoing a sitz bath regimen versus usual care. Findings from this study may contribute to more robust, multimodal postoperative pain management plans if proven efficacious or, alternatively, reduce plastic medical waste and simplify postoperative pain plans if found to be ineffective.

Frequently Asked Questions

What is SORE Study: Sitz Baths After Urogynecologic Reconstruction?

SORE Study: Sitz Baths After Urogynecologic Reconstruction is a clinical trial registered under NCT07215780. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT07215780?

The current status of NCT07215780 (SORE Study: Sitz Baths After Urogynecologic Reconstruction) is: ACTIVE_NOT_RECRUITING.

When did SORE Study: Sitz Baths After Urogynecologic Reconstruction start?

SORE Study: Sitz Baths After Urogynecologic Reconstruction started on 2025-10-28.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.